Loading resource…

KDIGO
The KDIGO 2025 Clinical Practice Guideline addresses the evaluation and treatment of anemia in patients with chronic kidney disease. It covers various aspects including the use of iron therapy, erythropoiesis-stimulating agents (ESAs), and red blood cell transfusions. The guideline emphasizes the importance of balancing risks and benefits when initiating treatment, particularly in relation to hemoglobin thresholds. It also includes algorithms for managing anemia in different patient populations.
No account needed